Expertise in
6
conditions

Dr. Evan L. Brittain

Cardiology
Vanderbilt Heart Transplant
1215 21st Ave S, 
Nashville, TN 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
6
conditions
Vanderbilt Heart Transplant
1215 21st Ave S, 
Nashville, TN 

Overview

Evan Brittain is a Cardiologist practicing medicine in Nashville, Tennessee.

Dr. Brittain is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Heart Failure, and Cardiomyopathy.

He is actively involved in clinical research, co-authoring 197 peer reviewed articles and participating in 8 clinical trials. Dr. Brittain is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in TN

Hospital Affiliations

Vanderbilt Tullahoma-Harton Hospital
Vanderbilt Bedford Hospital
Vanderbilt University Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Vanderbilt Heart Transplant
1215 21st Ave S, Nashville, TN 37232

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Ifetroban
Study Phase: Phase 2
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: September 30, 2025
Intervention Type: Dietary supplement
Study Phase: Phase 1
Activity Monitoring in Pulmonary Hypertension
Activity Monitoring in Pulmonary Hypertension
Enrollment Status: Active_not_recruiting
Publish Date: September 26, 2025
Intervention Type: Behavioral
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: December 05, 2024
Intervention Type: Drug
Study Drug: Tamoxifen
Study Phase: Phase 2
A Mobile Health Intervention in Pulmonary Arterial Hypertension
A Mobile Health Intervention in Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 25, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
Metabolic Intervention in the Right Ventricle in Pulmonary Arterial Hypertension
Metabolic Intervention in the Right Ventricle in Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: May 20, 2020
Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI
Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI
Enrollment Status: Completed
Publish Date: February 13, 2017
Intervention Type: Drug
Study Phase: Early Phase 1
View 7 Less Clinical Trials

197 Total Publications

Incidence and Clinical Associations With Phenotypic Drift From Pulmonary Arterial Hypertension to Combined Precapillary and Postcapillary Pulmonary Hypertension.
Incidence and Clinical Associations With Phenotypic Drift From Pulmonary Arterial Hypertension to Combined Precapillary and Postcapillary Pulmonary Hypertension.
Journal: CHEST pulmonary
Published: August 04, 2026
Similar Doctors
Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required
Before you request

Office

AA3228 21st Ave S, 
Nashville, TN 
 (1.9 miles away)
615-322-3000
Languages Spoken:
English
Accepting New Patients

Satish Raj is a Cardiologist practicing medicine in Nashville, Tennessee. Dr. Raj is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Familial Dysautonomia, Postural Orthostatic Tachycardia Syndrome (POTS), Low Blood Pressure, Orthostatic Hypotension, and Pacemaker Implantation. Dr. Raj is currently accepting new patients.

Expertise in
16
conditions
Dr. Dan M. Roden
Cardiology
Expertise in
16
conditions
Dr. Dan M. Roden
Cardiology
Referral required
Before you request

Vanderbilt University

3601 21st Ave S, 
Nashville, TN 
 (0.4 miles away)
615-322-3000
Languages Spoken:
English, Czech, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Dan Roden is a Cardiologist practicing medicine in Nashville, Tennessee. Dr. Roden is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Long QT Syndrome 5, Long QT Syndrome, Brugada Syndrome, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI). Dr. Roden is currently accepting new patients.

Expertise in
17
conditions
Dr. William G. Stevenson
Cardiac Electrophysiology | Cardiology
Expertise in
17
conditions
Dr. William G. Stevenson
Cardiac Electrophysiology | Cardiology
Referral may be required

Vanderbilt University Medical Center

1301 22nd Ave S, 
Nashville, TN 
 (0.1 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Stevenson is a Cardiac Electrophysiologist and a Cardiologist practicing medicine in Nashville, Tennessee. Dr. Stevenson is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Heart Transplant. Dr. Stevenson is currently accepting new patients.

Frequently Asked Questions about Dr. Evan L. Brittain

How do I make an appointment with Dr. Evan L. Brittain?

You can book an appointment with Dr. Evan L. Brittain by calling their office at 615-322-2318. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Evan L. Brittain a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Evan L. Brittain is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Evan L. Brittain specialize in?

While Dr. Evan L. Brittain is a Cardiology, they have specific expertise in Pulmonary Hypertension, Hypertension, and Heart Failure. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Evan L. Brittain participate in research or clinical trials?

Yes. Dr. Evan L. Brittain has published 197 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Evan L. Brittain's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Evan L. Brittain accept my insurance?

Dr. Evan L. Brittain accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 615-322-2318 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brittain's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile